Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin

Research output: Contribution to journalJournal articlepeer-review

  • Karoline Sidelmann Brinch
  • Paul M Tulkens
  • Francoise Van Bambeke
  • Niels Frimodt-Møller
  • Høiby, Niels
  • Hans-Henrik Kristensen
Staphylococcus aureus survives inside eukaryotic cells. Our objective was to assess the activity of NZ2114, a novel peptidic antibiotic, against intracellular S. aureus in comparison with established antistaphylococcal agents acting on the bacterial envelope with a distinct mechanism.
Original languageEnglish
JournalJournal of Antimicrobial Chemotherapy
Volume65
Issue number8
Pages (from-to)1720-4
Number of pages5
ISSN0305-7453
DOIs
Publication statusPublished - 1 Aug 2010

    Research areas

  • Anti-Bacterial Agents, Cell Line, Colony Count, Microbial, Daptomycin, Humans, Microbial Sensitivity Tests, Microbial Viability, Monocytes, Peptides, Staphylococcus aureus, Vancomycin

ID: 33917973